{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:50:53Z","timestamp":1696499453772},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.oftal.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T23:24:05Z","timestamp":1473463445000},"page":"93-96","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Imiquimod 5% t\u00f3pico como terapia alternativa en carcinoma basocelular periocular en 2 pacientes con contraindicaci\u00f3n quir\u00fargica"],"prefix":"10.1016","volume":"92","author":[{"given":"C.","family":"Costales-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u00c1lvarez-Coronado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rozas-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fern\u00e1ndez-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2016.07.002_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clindermatol.2014.10.008","article-title":"Eyelid and ocular surface carcinoma. Diagnosis and management","volume":"33","author":"Yin","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.oftal.2016.07.002_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0781.2011.00640.x","article-title":"Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: A case of series and review of the literature","volume":"28","author":"Attili","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.oftal.2016.07.002_bib0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1067\/mjd.2000.107808","article-title":"Inmunomodulatory and pharmacologic properties of imiquimod","volume":"43","author":"Saunder","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oftal.2016.07.002_bib0070","first-page":"1101","article-title":"Topical inmunomodulation in dermatology: Potential of Toll-like receptor agonist","volume":"30","author":"Hengge","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.oftal.2016.07.002_bib0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mjd.2002.123492","article-title":"Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis","volume":"47","author":"Persaud","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oftal.2016.07.002_bib0080","first-page":"669","article-title":"Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma","volume":"2","author":"Nouri","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.oftal.2016.07.002_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/01676830903294909","article-title":"The use of imiquimod in the treatment of periocular tumors","volume":"29","author":"Ross","year":"2010","journal-title":"Orbit"},{"key":"10.1016\/j.oftal.2016.07.002_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IOP.0b013e3181b8dd71","article-title":"Matoyoshi S. Imiquimod 5% cream for the treatment of periocular basal cell carcinoma","volume":"26","author":"Camargo","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.oftal.2016.07.002_bib0095","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/bjo.2009.178202","article-title":"The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions","volume":"95","author":"Cannon","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftal.2016.07.002_bib0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jop.2010.0030","article-title":"Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas","volume":"26","author":"Garc\u00eda-Mart\u00edn","year":"2010","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566911630123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566911630123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T15:50:00Z","timestamp":1536421800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036566911630123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S036566911630123X"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2016.07.002","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imiquimod 5% t\u00f3pico como terapia alternativa en carcinoma basocelular periocular en 2 pacientes con contraindicaci\u00f3n quir\u00fargica","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}